Excellos Ensures Reliability and Patient Safety with XiltriX

This case study is available as a downloadable PDF for offline reading.

Donor to Dose: Why CMC Matters in Cell and Gene Therapy Featuring Tr1x

Considerations for Donor Starting Material Characterization